Form 4: Immunovant COO Sells Shares to Cover Tax Withholding

Immunovant, Inc. reports that Chief Operating Officer Melanie Gloria sold 8,722 shares of common stock to cover tax withholding obligations upon the vesting of restricted stock units.

Summary

• Melanie Gloria, Chief Operating Officer of Immunovant, Inc., reported a transaction on April 8, 2026.
• The transaction involved the sale of 8,722 shares of common stock.
• These shares were sold at a weighted average price of $24.83, with individual sales ranging from $24.54 to $25.39.
• The sale was conducted to cover tax withholding obligations arising from the vesting of 19,045 restricted stock units (RSUs) that were granted on April 1, 2025.
• This 'sell to cover' transaction was mandated by the company and is not considered a discretionary sale by the reporting person.
• Following this transaction, Melanie Gloria beneficially owns 245,222 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the share sale was a mandatory action to cover tax obligations related to RSU vesting, rather than a discretionary decision to divest shares based on company performance or outlook.

Positives

• The sale was a mandatory 'sell to cover' transaction to satisfy tax obligations, indicating it was not a discretionary decision to divest shares.
• The reporting person still beneficially owns a significant number of shares (245,222) after the transaction.

Negatives

• A portion of the reporting person's vested equity was sold, reducing their direct shareholding.

Future Outlook

No specific future outlook or guidance is provided in this Form 4 filing, which solely reports a past transaction.

Industry Context

StockSavvy.ai notes that insider 'sell to cover' transactions are common when equity awards vest and are subject to tax withholding, generally not indicating a negative view of the company's prospects by the executive.

Stakeholder Impact

• Shareholders: The sale is a 'sell to cover' transaction and is not expected to have a significant impact on the stock price as it's a standard procedure for tax withholding. The reporting person retains a substantial number of shares.
• Employees: This transaction highlights the tax implications of equity compensation for executives and the common practice of using 'sell to cover' to manage these obligations.
• Management: The transaction reflects the standard management of equity-based compensation and associated tax liabilities.

Key Dates

Keywords

Immunovant, IMVT, Form 4, Insider Transaction, Stock Sale, Tax Withholding, RSU Vesting, Chief Operating Officer, Melanie Gloria